Proteomics and peptidomics for investigating metabolic and neurological disorders via liquid chromatography-mass spectrometry
Tan, Yanqi
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/130076
Description
Title
Proteomics and peptidomics for investigating metabolic and neurological disorders via liquid chromatography-mass spectrometry
Author(s)
Tan, Yanqi
Issue Date
2025-06-30
Director of Research (if dissertation) or Advisor (if thesis)
Sweedler, Jonathan
Doctoral Committee Chair(s)
Sweedler, Jonathan
Committee Member(s)
Leckband, Deborah
Yau, Peter
Shen, Mei
Department of Study
Chemistry
Discipline
Chemistry
Degree Granting Institution
University of Illinois Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Proteomics
Peptidomics
Mass Spectrometry
Neuropeptides
Abstract
Endogenous proteins and peptides play fundamental roles in cellular function, signaling, and disease pathogenesis. Their characterization provides critical insights into physiological processes and potential therapeutic targets. However, identifying and quantifying these biomolecules present significant analytical challenges due to their low abundance, complex biological matrices, and dynamic regulation. Mass spectrometry, particularly liquid chromatography-tandem mass spectrometry (LC-MS/MS), has emerged as a powerful tool for proteomic and peptidomic analysis, offering high sensitivity, selectivity, and structural characterization.
Depending on the purpose of a project, either untargeted or targeted MS approaches have been developed to optimize biomolecular analysis. Untargeted proteomics and peptidomics enable the broad characterization of proteins and peptides within a system without prior knowledge of their sequences. These approaches are instrumental in discovery-driven research, providing insights into novel biomarkers and disease mechanisms. High-resolution instruments such as quadrupole time-of-flight and Orbitrap mass spectrometers facilitate these analyses by offering high mass accuracy and resolving power. Recent advancements, including trapped ion mobility spectrometry coupled with parallel accumulation-serial fragmentation, enhance spectral clarity, sensitivity, and throughput, making large-scale proteomic and peptidomic studies more feasible. Targeted proteomics and peptidomics, in contrast, focus on quantifying predefined biomolecules with high specificity and reproducibility. These methods are essential for hypothesis-driven studies and biomarker validation. Triple quadrupole and high-resolution parallel reaction monitoring platforms enable precise quantification of target proteins and peptides. By integrating these approaches, both discovery-based and hypothesis-driven studies can be effectively performed, ensuring comprehensive and reliable characterization of biological systems.
This thesis includes my work in developing and optimizing high-sensitivity LC–MS/MS methods capable of femtogram-level quantification of endogenous proteins and peptides, significantly broadening our ability to detect critical biomarkers from minimal sample volumes. These advancements enable robust and precise analyses of trace-level biomolecules, including hemorphins in sickle cell disease models and glycated albumin in tear fluid, offering deeper insights into disease mechanisms, potential diagnostic tools, and therapeutic targets. Additionally, this research advances our understanding of exercise-derived extracellular vesicle proteomes as mediators of oxidative stress defense and vascular protection, providing a translational framework that extends to human health and broader clinical applications. Furthermore, this work includes the development of both label-free and isotopic labeling based approaches for opioid peptide measurement, enabling a more comprehensive investigation into quantitative peptidomics and providing deeper insights into peptide regulation. These methodological innovations contribute to the expanding toolkit of mass spectrometry-based proteomics and peptidomics, facilitating more sensitive and reproducible analyses across diverse biological and clinical applications.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.